Translational Development Acquisition Corp.(TDACU) - Prospectus(update)

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on November 19, 2024. Registration No. 333-282763 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | Cayman Islands | 6770 | N/A | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | Classification Code Number) | Identification Number) | Michael B. Hoffman Chief Executive Officer 52 E. 83rd Street, New York, New Y ...

Translational Development Acquisition Corp.(TDACU) - Prospectus(update) - Reportify